There has been documented data indicating a potential link between low levels of 25-hydroxyvitamin D and cardiovascular disease (CVD), as well as possible processes behind these disorders
WADA does not explicitly list AOD-9604 as a prohibited substance, but as an hGH analogue it falls under category S2
Given the significant uncertainties surrounding both retatrutide and 5-Amino-1MQ, consulting a qualified healthcare professional before considering either compound is strongly advisable and in practical terms, essential for safe decision-making
[13] There have also been rare reports of high-dose vitamin B (as in injectable form) precipitating skin outbreaks such as acne or rosacea in susceptible persons
Most clinics add vitamin B12
The oral tirzepatide research shows that even complex peptide agonists can potentially be reformulated for oral delivery, suggesting the same may eventually be possible for retatrutide-class compounds